Study at a glance
Why do vitamin D guidelines use different cut-offs?
Guidelines can ask different questions. Some focus on preventing bone disease across a population; others address particular clinical decisions or whether supplements improve a specific outcome. Different purposes can lead to different boundaries.
Can the same vitamin D result receive different labels?
Yes. One guideline may call a result insufficient while another places it above its main deficiency boundary. The person’s blood has not changed; the classification rule has.
Did the Endocrine Society change its vitamin D position?
Yes. Its 2024 prevention guidance no longer endorsed the older universal sufficiency and insufficiency categories for generally healthy people. That change does not mean severe vitamin D deficiency has stopped being important.
What should I check when reading a vitamin D cut-off?
Check who issued it, when it was issued, whom it applies to and what it is meant to predict. A deficiency boundary, a population benchmark and a treatment target are different things.
Read the full article below ↓One guideline may describe a vitamin D concentration as deficient, another may call the same concentration inadequate, and another may decline to attach a universal category at all. That can look like scientific contradiction. In reality, much of the disagreement comes from organisations asking different questions of the same 25-hydroxyvitamin D measurement.
The number is the same but the question can be different
A serum 25(OH)D result is a laboratory measurement. The interpretation placed on that result depends on what the guideline is trying to achieve. A public-health committee may ask what concentration should protect almost the entire population against poor skeletal outcomes. A clinical society may ask when treatment should be considered. A paediatric consensus group may focus on prevention of nutritional rickets. A trial-based guideline may ask whether screening people below a particular level improves disease outcomes.
Those are not interchangeable questions, which is why Vitamin D Deficiency Definitions cannot be reduced to one number without first identifying the framework behind it.
Different outcomes generate different boundaries
Vitamin D thresholds have been investigated using rickets, osteomalacia, calcium absorption, parathyroid hormone, bone turnover, bone mineral density and other outcomes. These endpoints do not all change at exactly the same 25(OH)D concentration.
A concentration selected because it covers the vitamin D requirements of nearly everybody is not automatically the same concentration at which a clinical deficiency disease begins. Likewise, a level proposed as a treatment target is not automatically a deficiency threshold. Vitamin D Thresholds vs Targets explains why these functions need to remain separate.
Guidelines also use different safety margins
Population guidance is often deliberately conservative. A recommended concentration or nutrient intake may be selected to meet the needs of almost everyone rather than to describe the minimum requirement of the average person. The National Academies’ vitamin D framework is a clear example: approximately 50 nmol/L was used as a level expected to cover nearly all healthy individuals, while the estimated median requirement was lower.
This is why population-level adequacy and personal physiology cannot be treated as identical concepts. The statistical distinction is developed further in Population Reference Ranges Explained.
The UK and US frameworks illustrate the difference
UK SACN concluded that the risk of poor musculoskeletal health increases below 25 nmol/L and used that finding when deriving national vitamin D intake recommendations. The National Academies, by contrast, identified below 30 nmol/L as associated with deficiency risk, 30 to below 50 nmol/L as potentially inadequate, and at least 50 nmol/L as sufficient for the needs of most healthy people.
The older 2011 Endocrine Society guideline adopted yet another system, defining deficiency below 50 nmol/L and insufficiency above that but below 75 nmol/L. Each framework consequently produces different numbers of people carrying each label.
Guidelines can change when the evidence question changes
The Endocrine Society itself provides an important example. Its 2011 guideline popularised specific deficiency and insufficiency thresholds. Its 2024 prevention guideline no longer endorsed those universal categories for generally healthy populations because clinical trials had not established outcome-specific 25(OH)D thresholds sufficiently well.
This is not evidence that 25(OH)D ceased to matter. It shows that a biochemical association and a proven clinical-trial treatment threshold are different evidential claims.
Why one person can receive two different labels
Consider a person with a 25(OH)D concentration of 45 nmol/L. That concentration can sit above a severe-deficiency boundary, below a population sufficiency reference, or inside an insufficiency category depending on the guideline being used. The person’s biology has not changed when the reference framework changes.
This is especially important when interpreting Vitamin D Insufficiency Explained and Vitamin D Sufficiency Explained. Both labels inherit the assumptions of the system that defines their boundaries.
Measurement adds uncertainty around every cut-off
Even an agreed boundary does not eliminate uncertainty. 25(OH)D assays have historically shown enough inter-method and inter-laboratory variation for samples near a decision threshold to be classified differently. Standardisation has improved measurement, but no quantitative laboratory test has infinite precision.
This is why Limitations of Vitamin D Blood Tests becomes particularly relevant when a result lies close to a category boundary. A tiny difference in reported concentration should not automatically be interpreted as a dramatic difference in physiology.
Clinical disease is not diagnosed from a cut-off alone
Nutritional rickets makes this especially clear. International consensus uses a biochemical vitamin D classification, but the diagnosis of rickets also depends on history, clinical examination, biochemical findings and radiographic evidence. Calcium intake modifies the risk, and prolonged low vitamin D status matters more than an isolated number.
A biochemical category therefore contributes to diagnosis without replacing clinical reasoning.
The disagreement becomes smaller at the extremes
Guidelines disagree most about the intermediate range where the question shifts from clear deficiency risk toward adequacy, insufficiency or optimisation. At very low and sustained 25(OH)D concentrations, concern for defective mineral metabolism is much more consistent.
That pattern is important. It means disagreement over a 20, 25, 30, 50 or 75 nmol/L decision point should not be misread as evidence that severe vitamin D deficiency is imaginary. The controversy concerns where probability should be converted into a categorical label and what that label is intended to predict.
How to read a vitamin D deficiency threshold responsibly
Before interpreting any cut-off, ask four questions: which organisation established it, which population it applies to, which outcome it was designed to protect or predict, and whether the number describes deficiency, population adequacy, a treatment target or research classification.
Once those questions are answered, apparently conflicting guidelines become easier to reconcile. Their numbers can differ because their purposes differ.
The useful conclusion is context, not numerical nihilism
Recognising the limitations of vitamin D cut-offs does not mean ignoring measured status or assuming that every concentration is equivalent. It means using numbers for the jobs the evidence actually supports.
A 25(OH)D concentration remains valuable information. Its interpretation becomes stronger, not weaker, when the guideline purpose, outcome, population, measurement uncertainty and wider physiological context are kept visible. The result is a more accurate understanding of deficiency: neither a meaningless label nor a universal switch, but a clinically useful classification whose meaning depends on the evidence framework behind it.
Primary evidence and guidance
Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011. PMID: 21796828. DOI: 10.17226/13050.
Scientific Advisory Committee on Nutrition. Vitamin D and Health. Public Health England; 2016.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. PMID: 21646368. DOI: 10.1210/jc.2011-0385.
Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. PMID: 38828931. DOI: 10.1210/clinem/dgae290.
Munns CF, Shaw N, Kiely M, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016;101(2):394-415. PMID: 26745253. PMCID: PMC4880117. DOI: 10.1210/jc.2015-2175.
Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship between Vitamin D, Parathyroid Hormone, and Bone Health. J Clin Endocrinol Metab. 2011;96(3):E436-E446. PMID: 21159838. PMCID: PMC3047227. DOI: 10.1210/jc.2010-1886.
Sempos CT, Wise SA, Phinney KW, et al. Baseline Assessment of 25-Hydroxyvitamin D Assay Performance: A Vitamin D Standardization Program (VDSP) Interlaboratory Comparison Study. J AOAC Int. 2017;100(5). PMID: 28822355. DOI: 10.5740/jaoacint.17-0258.
Related reading
Development of a Short Questionnaire for the Screening for Vitamin D Deficiency in Italian Adults: The EVIDENCe-Q Project
Methods: 150 participants, attending the 11Clinical Nutrition and Dietetics Operative Unit, Internal Medicine and Endocrinology, Istituti Clinici Scientifici Maugeri IRCCS, of Pavia were enrolled.
Original paper ↗Read more →Impact of nutritional status on mortality in geriatric patients with osteoporosis: a retrospective cohort study
This study investigated the relationship between mortality and numerous characteristics in geriatric patients with osteoporosis, including nutritional, clinical, anthropometric, and biochemical factors.
Original paper ↗Read more →Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy
The aim of this study was to evaluate the combined effect of maternal and neonatal VDR polymorphisms (ApaI, TaqI, BsmI, FokI, Tru9I) and different maternal and neonatal 25(OH)D cut-offs on neonatal birth anthropometry.
Original paper ↗Read more →Physiological Limitations of Vitamin D Deficiency Cut-Offs and Diagnostic Thresholds: Full Study
Review the physiological limitations of vitamin D deficiency cutoffs, including PTH, calcium intake, assay variation and individual biological differences.
Read more →Why Vitamin D Insufficiency Is Not a Universal Cut-Off
Learn why vitamin D insufficiency has no universal numerical cut-off and how physiology, guideline purpose, population thresholds and measurement variability affect interpretation.Page type: Context.
Read more →A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health
Vitamin D3 has many important health benefits.
Original paper ↗Read more →Serum 25-hydroxyvitamin D threshold and risk of rickets in young children: a systematic review and individual participant data meta-analysis to inform the development of dietary requirements for vitamin D
The objective of this systematic review was to determine a minimum serum 25-hydroxyvitamin D (25OHD) threshold based on the risk of having rickets in young children.
Original paper ↗Read more →Vitamin D Thresholds vs Targets
Explore the difference between vitamin D thresholds and targets, why numbers vary between people, and how physiology and context shape meaningful interpretation.
Read more →Association between serum 25-hydroxyvitamin D levels and Early Vascular Aging in young and middle-aged adults
Participants were categorized into EVA group (n = 687) and control group (n = 1360) based on brachial ankle pulse wave velocity (baPWV).
Original paper ↗Read more →Association between serum 25-hydroxyvitamin D, nutritional status, and inflammatory markers in sepsis patients with and without sarcopenia
The current study aimed to address this gap by exploring 25(OH)D cut-off values with potential discriminatory value for sepsis and sepsis with sarcopenia, particularly in a Chinese patient population where relevant data remain scarce.
Original paper ↗Read more →Association between Suboptimal 25-Hydroxyvitamin D Status and Overweight/Obesity in Infants: A Prospective Cohort Study in China
This study aimed to investigate whether 25-hydroxyvitamin D (25(OH)D) concentrations are correlated to overweight/obesity in infants and to explore a threshold of 25(OH)D.
Original paper ↗Read more →Associations between serum 25(OH)D concentrations and prevalent asthma among children living in communities with differing levels of urbanization: a cross-sectional study
Prior evidence suggests that vitamin D deficiency may increase the risk of asthma and atopy and impair pulmonary function in children.
Original paper ↗Read more →Dose-Response Relationship Between Serum 25(OH)D and the Risk of Abnormal Glycemic Status in Chinese Older Adults
Background/Objectives: The relationship between serum 25-hydroxyvitaminD (25(OH)D) concentration and the risk of abnormal glycemic status remains contradictory.
Original paper ↗Read more →No effect of 25-hydroxyvitamin D supplementation on the skeletal muscle transcriptome in vitamin D deficient frail older adults
The aim of this study was to investigate the effect of calcifediol (25-hydroxycholecalciferol) on whole genome gene expression in skeletal muscle of vitamin D deficient frail older adults.
Original paper ↗Read more →Non-Linear Relationship between Serum 25-Hydroxyvitamin D and Hemoglobin in Korean Females: The Korean National Health and Nutrition Examination Survey 2010 to 2011
Anemia and vitamin D deficiency are both important health issues; however, the nature of the association between vitamin D and either hemoglobin or anemia remains unresolved in the general population.
Original paper ↗Read more →Plasma 25-hydroxyvitamin D level and the risk of frailty among Chinese community-based oldest-old: evidence from the CLHLS study
The aim of this study was to examine the association between plasma 25-hydroxyvitamin D [25(OH)D] levels and the risk of frailty among the Chinese community based oldest-old.
Original paper ↗Read more →Quantitative Ultrasound Assessment of Skeletal Muscle Microvascularity in Relation to Serum 25-Hydroxyvitamin D Concentrations
In contrast, VI values were significantly higher in participants with higher serum 25(OH)D levels across all examined muscles (p < 0.001).
Original paper ↗Read more →Relationship Between Total 25-Hydroxyvitamin D and Parathyroid Hormone Concentrations During Early Gestation in Indian Women
The inverse relationship between 25(OH)D and parathyroid hormone (PTH) concentrations was examined to define the breakpoint at which PTH was maximally suppressed using a segmented regression analysis.
Original paper ↗Read more →Serum 25-hydroxyvitamin D levels among women newly diagnosed with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
This study aimed to assess serum 25-hydroxyvitamin D [25(OH)D] levels in Ethiopian women newly diagnosed with BC compared to healthy controls.
Original paper ↗Read more →Serum 25(OH)D levels and mortality risk among middle-aged and elderly populations in the U.S.: A prospective cohort study
A total of 22,130 participants aged 40 to 70 years were included.
Original paper ↗Read more →Standardization of Misleading Immunoassay Based 25-Hydroxyvitamin D Levels with Liquid Chromatography Tandem-Mass Spectrometry in a Large Cohort Study
The interest in vitamin D measurement has strongly increased in recent years.
Original paper ↗Read more →Original sources
Dietary Reference Intakes for Calcium and Vitamin D
Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium.
Publication details
Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011. PMID: 21796828. DOI: 10.17226/13050.
Vitamin D and Health
Scientific Advisory Committee on Nutrition.
Publication details
Scientific Advisory Committee on Nutrition. Vitamin D and Health. Public Health England; 2016.
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline
Published in J Clin Endocrinol Metab (2011).
Publication details
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. PMID: 21646368. DOI: 10.1210/jc.2011-0385.
Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline
Published in J Clin Endocrinol Metab (2024).
Publication details
Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. PMID: 38828931. DOI: 10.1210/clinem/dgae290.
Global Consensus Recommendations on Prevention and Management of Nutritional Rickets
Published in J Clin Endocrinol Metab (2016).
Publication details
Munns CF, Shaw N, Kiely M, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016;101(2):394-415. PMID: 26745253. PMCID: PMC4880117. DOI: 10.1210/jc.2015-2175.
Relationship between Vitamin D, Parathyroid Hormone, and Bone Health
Published in J Clin Endocrinol Metab (2011).
Publication details
Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship between Vitamin D, Parathyroid Hormone, and Bone Health. J Clin Endocrinol Metab. 2011;96(3):E436-E446. PMID: 21159838. PMCID: PMC3047227. DOI: 10.1210/jc.2010-1886.
Baseline Assessment of 25-Hydroxyvitamin D Assay Performance: A Vitamin D Standardization Program (VDSP) Interlaboratory Comparison Study
Published in J AOAC Int (2017).
Publication details
Sempos CT, Wise SA, Phinney KW, et al. Baseline Assessment of 25-Hydroxyvitamin D Assay Performance: A Vitamin D Standardization Program (VDSP) Interlaboratory Comparison Study. J AOAC Int. 2017;100(5). PMID: 28822355. DOI: 10.5740/jaoacint.17-0258.